| Title | A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Fulvestrant in Subjects With HR+/HER2- Advanced or Metastatic Breast Cancer |
|---|---|
| Disease/Condition | Breast Cancer,Skin Disorders,Medical and Hematologic Oncology,Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Sun Young Oh, MD |
| Contact Name | Priscilla Vazquez |
| Contact Email | pvazquez@montefiore.org |
| Protocol Number | 16-06-378-01 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | HR+/HER2- Breast Cancer |
| Adult, Pediatric, Both | Adult |